
WALD Stock Forecast & Price Target
WALD Analyst Ratings
Bulls say
Waldencast is facing challenges due to underperforming results, and management's decision not to provide guidance for FY26. The company's recent financials have been adversely affected by slower than expected growth and elevated margin pressure. However, the company is taking measures to improve its performance, including conducting a strategic review to maximize shareholder value. The success of Obagi's entry into the filler market and its momentum in eCommerce channels provides potential for growth, but execution risk remains. Milk's recent struggles and international demand issues have caused management to reorganize the brand.
Bears say
Waldencast is facing several challenges that could hinder its future growth and profitability. The company's reliance on third-party suppliers and potential dilution from securities offerings could lead to disruptions in its business and negatively impact its stock price. Furthermore, the company's heavy dependence on one distributor for its Obagi products in the highly competitive beauty market could limit its growth potential. The ongoing SEC investigation and potential for slowed growth in the beauty market could also add pressure to the company's financials.
This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.
WALD Analyst Forecast & Price Prediction
Start investing in WALD
Order type
Buy in
Order amount
Est. shares
0 shares